What is the likely diagnosis and recommended management for a patient with a two‑day history of left upper arm paresthesia and burning pain without any rash?

Likely Diagnosis: Pre-Eruptive Herpes Zoster (Shingles)

The most likely diagnosis is herpes zoster (shingles) in the pre-eruptive phase, and the patient should be started immediately on high-dose oral antiviral therapy (valacyclovir 1000 mg three times daily or famciclovir 500 mg three times daily for 7 days) without waiting for rash development.

Clinical Reasoning

The presentation of dermatomal burning pain with tingling (paresthesias) that precedes visible skin lesions by 24-72 hours (sometimes longer) is the classic prodrome of herpes zoster 1. This is a critical diagnostic window where early antiviral intervention provides maximum benefit.

Key Diagnostic Features Supporting Herpes Zoster:

• Unilateral distribution in a single dermatome (left upper arm)
• Burning, tingling quality of pain (neuropathic characteristics)
• Two-day duration falls within the typical 24-72 hour prodromal period before vesicular eruption
• Absence of rash does not exclude the diagnosis—pain precedes visible lesions in the majority of cases 1, 2, 1

Why Immediate Treatment is Critical:

Antiviral therapy must be initiated within 72 hours of symptom onset to be effective 1. Since the patient is already at day 2, there is only a narrow window remaining. Waiting for rash development will likely result in missing the therapeutic window entirely.

Recommended Management Algorithm

Immediate Actions (Do Not Delay):

1. Start oral antiviral therapy immediately:

   • Valacyclovir 1000 mg three times daily for 7 days, OR
   • Famciclovir 500 mg three times daily for 7 days 1
   • These high-dose regimens are specifically for VZV (not the lower doses used for HSV)

2. Provide analgesics for pain control while awaiting antiviral effect

3. Instruct patient to monitor for rash development over next 24-48 hours in the same dermatomal distribution

If Rash Develops:

• Continue the full 7-day antiviral course
• Monitor for complications (dissemination, secondary bacterial infection, ocular involvement if facial)
• Consider extending treatment if new lesions continue to appear beyond 7 days

If No Rash Develops After 72 Hours:

Consider alternative diagnoses in this order of likelihood:

1. Peripheral nerve entrapment or injury (lateral antebrachial cutaneous nerve, radial nerve, or brachial plexus pathology) 3, 4, 5, 6

   • Look for: History of trauma, repetitive activities, positional symptoms, weakness in specific muscle groups
   • Next step: Electrodiagnostic studies (EMG/NCS) if symptoms persist beyond 2 weeks

2. Cervical radiculopathy (C5-C6 nerve root)

   • Look for: Neck pain, symptoms with neck movement, dermatomal sensory loss, reflex changes
   • Next step: MRI cervical spine if red flags present (progressive weakness, bowel/bladder dysfunction)

3. Brachial plexopathy

   • Look for: Symptoms crossing multiple nerve distributions, preceding viral illness, severe pain out of proportion
   • Next step: MRI brachial plexus with neurography sequences 7

Critical Pitfalls to Avoid

Do not wait for rash to appear before starting antivirals. The evidence clearly shows that herpes zoster pain precedes skin findings by 24-72 hours or longer 1, 2, 1. By the time vesicles appear, you may have already missed the optimal treatment window.

Do not use low-dose acyclovir regimens. The doses for VZV are substantially higher than those for HSV: valacyclovir 1000 mg TID (not 500 mg BID) or famciclovir 500 mg TID (not 250 mg BID) 1.

Do not assume the patient is immunocompetent. Ask specifically about: HIV status, diabetes, cancer history, immunosuppressive medications, recent chemotherapy, or transplant history. If immunocompromised, consider IV acyclovir instead of oral therapy 1.

Why This Approach Prioritizes Morbidity and Quality of Life

Early antiviral treatment of herpes zoster:

• Reduces acute pain duration and severity
• Decreases risk of postherpetic neuralgia (the most debilitating long-term complication)
• Accelerates healing and reduces viral shedding
• Prevents dissemination in at-risk patients

The risk-benefit ratio strongly favors empiric treatment: oral antivirals are well-tolerated with minimal adverse effects (primarily mild headache and nausea in <10% of patients) 8, while untreated herpes zoster can lead to chronic neuropathic pain lasting months to years that significantly impairs quality of life.

If this turns out not to be herpes zoster, a 7-day course of oral antivirals causes minimal harm. If it is herpes zoster and you delay treatment, you may condemn the patient to months of severe postherpetic neuralgia.